|
Press Releases |
|
|
|
Friday, April 17, 2015 |
|
Cytokinetics to Announce First Quarter Results on April 30, 2015 |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to report first quarter results on Thursday, April 30, 2015 at 4:00 PM Eastern Time. more info >> |
|
Tuesday, April 14, 2015 |
|
Cytokinetics to Host R&D Day on Tuesday, May 12, 2015 |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to host its Research and Development Day on Tuesday, May 12, 2015. more info >> |
|
Thursday, April 9, 2015 |
|
Cytokinetics to Present at the 14th Annual Needham Healthcare Conference |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the 14th Annual Needham Healthcare Conference on Wednesday, April 15, 2015 at 11:20 AM at the Westin New York Grand Central in New York, NY. more info >> |
|
Thursday, March 26, 2015 |
|
Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced the publication of a manuscript relating to its fast skeletal muscle troponin activator tirasemtiv in the journal Neurotherapeutics. more info >> |
|
Friday, March 13, 2015 |
|
Cytokinetics Announces Completion of Enrollment in COSMIC-HF |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure) has completed enrollment of the approximately 450 patients planned in the expansion phase of the clinical trial. more info >> |
|
Friday, February 27, 2015 |
|
Cytokinetics Announces Publication of Preclinical Data Relating to CK-2127107 and Exercise Tolerance in Rodent Model of Heart Failure |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced the publication of a manuscript relating to its fast skeletal muscle troponin activator CK-2127107 in The Journal of Pharmacology and Experimental Therapeutics. more info >> |
|
Wednesday, February 25, 2015 |
|
Cytokinetics to Present at Healthcare Conferences in March |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the following healthcare conferences. more info >> |
|
Friday, February 13, 2015 |
|
Cytokinetics, Incorporated Reports Fourth Quarter 2014 Financial Results |
Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research and development revenues for the fourth quarter of 2014 were $21.8 million, compared to $24.3 million during the same period in 2013. more info >> |
|
Tuesday, December 23, 2014 |
|
Cytokinetics and Astellas Announce Expansion of Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications |
Cytokinetics, Incorporated (NASDAQ:CYTK) and Astellas Pharma Inc. (Tokyo Stock Exchange: 4503, "Astellas") announced today an amendment to their collaboration agreement focused on the research, development and commercialization of skeletal muscle activators. more info >> |
|
Saturday, December 6, 2014 |
|
Cytokinetics Announces Presentations Relating to Tirasemtiv and Effects on Respiratory Muscle Function at International Symposium on ALS/MND |
Cytokinetics (Nasdaq: CYTK) announced today that an oral presentation and four poster presentations relating to tirasemtiv were presented at the 25th International Symposium on ALS/MND held at the Square Brussels Meeting Centre in Brussels, Belgium. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Paltalk to Host First Quarter 2024 Earnings Results Conference Call on Thursday, May 9, 2024 at 9:00 a.m. ET
May 2, 2024 00:28 HKT/SGT
|
|
|
PodcastOne (Nasdaq: PODC) Acquires Exclusive Sales and Distribution Rights to Dumb Gay Podcast
May 2, 2024 00:19 HKT/SGT
|
|
|
Forian Inc. to Announce First Quarter 2024 Results on May 14, 2024
May 2, 2024 00:09 HKT/SGT
|
|
|
Vietnam to Rethink Financial Services After a Cutting-edge Show at WFIS
May 1, 2024 16:42: JST
|
|
|
Vietnam to Rethink Financial Services After a Cutting-edge Show at WFIS
May 1, 2024 15:42 HKT/SGT
|
|
|
国美金融科技发布2023年度报告 商业保理稳中向好 多元化协同发展
May 1, 2024 13:18 HKT/SGT
|
|
|
國美金融科技發佈2023年度報告 商業保理穩中向好 多元化協同發展
May 1, 2024 13:12 HKT/SGT
|
|
|
Anson Resources Signs Lithium Supply Agreement with LG Energy Solution
May 1, 2024 09:00 HKT/SGT
|
|
|
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024
Apr 30, 2024 19:40 HKT/SGT
|
|
|
Q2 Metals Announces Completion of Drill-Core Re-Evaluation for the Cisco Lithium Property, James Bay Territory, Quebec, Canada
Apr 30, 2024 19:09 HKT/SGT
|
|
|
Sumitomo Metal Mining and Mitsubishi Corporation to Participate in Kalgoorlie Nickel Project - Goongarrie Hub
Apr 30, 2024 19:08 JST
|
|
|
Hong Kong Gifts, printing and packaging, and licensing events foster cross-industry opportunities
Apr 30, 2024 18:00 HKT/SGT
|
|
|
Moolec Announces New Patent Granting in the United States for Molecular Farming Platform
Apr 30, 2024 18:00 HKT/SGT
|
|
|
DCCI fortifies stance for Malaysia's greatest show: Wins support from key government organisations
Apr 30, 2024 17:56 HKT/SGT
|
|
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
Apr 30, 2024 18:00 JST
|
|
|
|
More News >> |
|
|
|
|
|